Fact Sheet: President Donald J. Trump Announces Deal with Regeneron to Bring Most-Favored-Nation Pricing to American Patients

ADVANCING MOST-FAVORED-NATION (MFN) PRICING: Today, President Donald J. Trump announced the 17th agreement with a major pharmaceutical manufacturer, Regeneron, to lower prescription drug prices that Americans pay for some of the world’s most innovative drugs, in line with the lowest prices paid by other developed nations (known as the most-favored-nation, or MFN, price).   The

US Warns of ‘Industrial-Scale’ Efforts by China to Extract AI Technology

White House Chief Technology Officer Michael Kratsios gives a speech on the last day of the Web Summit in Lisbon on Nov. 7, 2019. Patricia De Melo Moreira/AFP via Getty Images The White House said on April 23 that China and other foreign adversaries are carrying out “industrial-scale campaigns” to extract advanced American artificial intelligence